Cabaletta Bio (CABA) announced that it has commenced an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of its common stock and, in lieu of common stock, to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying warrants to purchase shares of its common stock. All of the shares, pre-funded warrants and accompanying common stock warrants to be sold in the proposed offering are to be sold by Cabaletta. Jefferies, TD Cowen and Cantor are acting as joint book-running managers for the proposed offering. The offering is expected to close on or about June 12, subject to customary closing conditions.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CABA:
- Cabaletta Bio reports data from the RESET trials evaluating rese-cel
- Cabaletta Bio Stockholders Approve Key Proposals
- Cabaletta Bio Reprices Stock Options to Motivate Staff
- Biotech Alert: Searches spiking for these stocks today
- Cabaletta Bio: Hold Rating Amid Cash Constraints and Regulatory Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue